Wikidata

(Q65384538)

English

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

clinical trial

In more languages

Statements

short name
Beyond (English)
0 references
title
International, Multicenter, Phase IIIb Study of Subcutaneous Every-other-day Treatment of Patients With Relapsing Multiple Sclerosis With (Phase A): Double-blind Betaseron/Betaferon 250µg or 500µg or Open-label Betaseron/Betaferon 250µg and (Phase B): Open-label Betaseron/Betaferon 500µg (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Latvia
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Slovenia
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Ukraine
0 references
start time
May 2007
0 references
end time
March 2008
0 references
number of participants
1,420
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65384538&oldid=1858396587"